Bevacizumab at recurrence in high-grade glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab at recurrence in high-grade glioma

Published:2011-10-07 Issue:S2 Volume:32 Page:251-253
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Salmaggi Andrea,Gaviani Paola,Botturi Andrea,Lamperti Elena,Simonetti Giorgia,Ferrari Daniela,Silvani Antonio

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-011-0799-6.pdf

Reference14 articles.

1. Salmaggi A, Eoli M, Frigerio S et al (2003) Intracavitary VEGF, bFGF, IL-8 and IL-12 levels in primary and recurrent malignant glioma. J Neurooncol 62:297–303

2. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

3. Sandler A, Gray R, Perry MC et al (2006) Paclitaxel-Carboplatin alone or with bevacizumab for non small cell lung cancer. N Engl J Med 355:2542–2550

4. Wedam SB, Low JA, Yang SX et al (2006) Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol 24:769–777

5. Vredenburgh JJ, Desjardins A, Herndon JE II et al (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722–4729

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging immune-based technologies for high-grade gliomas;Expert Review of Anticancer Therapy;2022-08-12

2. Radio-pathomic maps of cell density identify glioma invasion beyond traditional MR imaging defined margins;2021-04-09

3. Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I);Brain Sciences;2021-03-18

4. Passive Immunotherapeutic Strategies for the Treatment of Malignant Gliomas;Neurosurgery Clinics of North America;2012-07

5. Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme;Neurosurgery Clinics of North America;2012-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3